These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 15254209)

  • 1. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus.
    Lee CW; Senne DA; Suarez DL
    J Virol; 2004 Aug; 78(15):8372-81. PubMed ID: 15254209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary Dynamics of Mexican Lineage H5N2 Avian Influenza Viruses.
    Xu W; Navarro-López R; Solis-Hernandez M; Liljehult-Fuentes F; Molina-Montiel M; Lagunas-Ayala M; Rocha-Martinez M; Ferrara-Tijera E; Pérez de la Rosa J; Berhane Y
    Viruses; 2022 May; 14(5):. PubMed ID: 35632700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico.
    Horimoto T; Rivera E; Pearson J; Senne D; Krauss S; Kawaoka Y; Webster RG
    Virology; 1995 Oct; 213(1):223-30. PubMed ID: 7483266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence analysis of related low-pathogenic and highly pathogenic H5N2 avian influenza isolates from United States live bird markets and poultry farms from 1983 to 1989.
    Suarez DL; Senne DA
    Avian Dis; 2000; 44(2):356-64. PubMed ID: 10879916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
    Bertran K; Criado MF; Lee DH; Killmaster L; Sá E Silva M; Lucio E; Widener J; Pritchard N; Atkins E; Mebatsion T; Swayne DE
    Vaccine; 2020 Feb; 38(6):1526-1534. PubMed ID: 31862196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antigenic and genetic drift on the serologic surveillance of H5N2 avian influenza viruses.
    Escorcia M; Carrillo-Sánchez K; March-Mifsut S; Chapa J; Lucio E; Nava GM
    BMC Vet Res; 2010 Dec; 6():57. PubMed ID: 21172021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus.
    Swayne DE; Beck JR; Mickle TR
    Avian Dis; 1997; 41(4):910-22. PubMed ID: 9454926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
    Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence and evolution of avian H5N2 influenza viruses in chickens in Taiwan.
    Lee CC; Zhu H; Huang PY; Peng L; Chang YC; Yip CH; Li YT; Cheung CL; Compans R; Yang C; Smith DK; Lam TT; King CC; Guan Y
    J Virol; 2014 May; 88(10):5677-86. PubMed ID: 24623422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenetic analysis, molecular changes, and adaptation to chickens of Mexican lineage H5N2 low-pathogenic avian influenza viruses from 1994 to 2019.
    Youk S; Leyson CM; Parris DJ; Kariithi HM; Suarez DL; Pantin-Jackwood MJ
    Transbound Emerg Dis; 2022 Sep; 69(5):e1445-e1459. PubMed ID: 35150205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of H5N2 influenza viruses from Italian poultry.
    Donatelli I; Campitelli L; Di Trani L; Puzelli S; Selli L; Fioretti A; Alexander DJ; Tollis M; Krauss S; Webster RG
    J Gen Virol; 2001 Mar; 82(Pt 3):623-630. PubMed ID: 11172104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico.
    García M; Crawford JM; Latimer JW; Rivera-Cruz E; Perdue ML
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1493-504. PubMed ID: 8757992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency, efficacy, and antigenic mapping of H7 avian influenza virus vaccines against the 2012 H7N3 highly pathogenic avian influenza virus from Mexico.
    Spackman E; Wan XF; Kapczynski D; Xu Y; Pantin-Jackwood M; Suarez DL; Swayne D
    Avian Dis; 2014 Sep; 58(3):359-66. PubMed ID: 25518428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.